India Business Excellence Fund III Sells 30 Lakh Molbio Diagnostics Shares

Molbio Diagnostics Limited has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. India Business Excellence Fund III, a scheme of Business Excellence Trust III, has sold an aggregate of 30,00,000 equity shares of Molbio Diagnostics Limited on September 23, 2026. This sale resulted in a decrease in their shareholding from 11,52,39,996 shares to 11,22,39,996 shares. The transaction was conducted via open market sale. The computed percentage change in holding is not explicitly stated but can be inferred from the change in absolute numbers.